Additionally, the association was stronger in patients with fewer traditional cardiovascular risk factors, suggesting that anti-Ro/La antibodies may contribute to CAD through distinct, inflammation-mediated mechanisms. The gene discussed is CALR; the disease is coronary artery disorder.